| Literature DB >> 35226145 |
Charlotte Delacroix1, Lucie Allegre2, Kyriaki Chatziioannidou2,3, Armance Gérard2, Brigitte Fatton2, Renaud de Tayrac2.
Abstract
INTRODUCTION AND HYPOTHESIS: Anterior bilateral sacrospinous ligament fixation (ABSSLF) was first described in 2000 but only evaluated in a limited number of studies. However, due to the FDA's ban on transvaginal mesh, interest in this technique has re-emerged. The SSLF procedure is known for its inherent high risk for anterior compartment failure; hence, in our center we started performing a preemptive concomitant anterior repair with the intention to reduce such risk. The aim of this study was to review the feasibility and clinical outcomes of this innovative technique.Entities:
Keywords: Anterior approach; Bilateral sacrospinous ligament fixation (BSSLF); Native tissue repair; Pelvic organ prolapse; Uterosacral ligament suspension; Vaginal prolapse repair
Year: 2022 PMID: 35226145 PMCID: PMC8883458 DOI: 10.1007/s00192-022-05092-x
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 2.894
Fig. 1Surgical technique
Baseline characteristics of the study population (n = 50)
| Median [IQR] or | |
|---|---|
| Demographics | |
| Age | 72 [8] |
| BMI | 24 [7] |
| Parity | 2 [2] |
| Postmenopausal | 49 (98) |
| Diabetics | 6 (12) |
| Smoker | 3 (6) |
| Prior surgeries | |
| Hysterectomy | 3 (6) |
| Prolapse surgery | 6 (12) |
| Urinary incontinence surgery | 2 (4) |
| Sexually activity status | |
| Sexually active | 32 (71) |
| Not sexually active | 13 (29) |
| Unknown | 5 |
BMI body mass index
Operative parameters and perioperative complications (n = 50)
| Median [IQR] or | |
|---|---|
| Anesthesia | |
| General | 34 (68) |
| Spinal | 16 (32) |
| Local | 0 |
| Procedure | |
| ABSSLF with cystocele repair exclusive | 12 (24) |
| Concomitant surgery | 38 (76) |
| Rectocele repair | 31 (62) |
| Hysterectomy | 10 (20) |
| Midurethral sling for stress incontinence | 2 (4) |
| Surgery time, min | |
| ABSSLF with cystocele repair exclusive | 70 [16] |
| Concomittent surgery included | 126 [20] |
| ABSSLF feasibility | 50 (100) |
| ABSSLF procedure | |
| Anatomical suspension | |
| Hysteropexy | 37 (74) |
| Uterosacral ligament fixation | 13 (26) |
| Suture technique | |
| PP sutures | 28 (60) |
| PP sutures + tape | 19 (40) |
| ND | 3 |
| Early morbidities (< 15 days) | |
| Overall | 20 (40) |
| Clavien-Dindo classification | |
| I | 2 (4) |
| II | 17 (34) |
| IIIb | 1 (2) |
| IV | 0 |
| V | 0 |
| IUGA classification | |
| 4BeT1S5 | 16 (32) |
| 4CeT1S5 | 1 (2) |
| 6BeT1S4 | 1 (2) |
| 4BeT2S5 | 8 (16) |
| 2BT2S1 | 1 (2) |
| Category | |
| Ureteral stenosis | 1 (2) |
| Urinary tract infection | 7 (14) |
| Urinary retention | 8 (16) |
| Self-catheterization | 14 (28) |
| Self-catheterization > 10 days | 5 (10) |
| Scar disunion | 1 (2) |
| Hematoma | 0 |
| Acute neurological pain | 0 |
| New hospitalization | 0 |
| New reintervention | 1 (2) |
| Late morbidities (15 days to 10 months) | |
| Overall | 4 (8) |
| IUGA classification | |
| 4BaT3S5 | 1 (2) |
| 6BbT3S4 | 1 (2) |
| 6BeT3S5 | 1 (2) |
| 2AaT4S1 | 1 (2) |
| Category | |
| Chronic pelvic pain | 2 (4) |
| Vaginal tape exposition | 2 (4) |
IQR interquartile range, ABSSLF anterior bilateral sacrospinous ligament fixation, ND non-data
Comparative anatomical results before surgery and at follow-up (median follow-up time = 10 months)
| Before surgery | After surgery | Pre- to postoperative median difference and 95% [CI] | ||
|---|---|---|---|---|
| POP Q points (centimeters) | ||||
| Ba | < 0.001 | |||
| Min | –2.5 | –3 | ||
| Med [IQR] | 2 [3.5] | –2 [1.5] | 3.5 [2.7–4.5] | |
| Max | 6 | 1 | ||
| C | < 0.001 | |||
| Min | –7 | –8 | ||
| Med [IQR] | 1 [3] | –6 [2] | 7 [5.5–8] | |
| Max | 8 | –2 | ||
| Bp | < 0.001 | |||
| Min | –3 | -3 | ||
| Med [IQR] | –1 [–1.75] | –3 [0.5] | 1.5 [0.75–2.25] | |
| Max | 1 | 2 | ||
| POP Q stage ( | ||||
| Global | ||||
| 0 | 0 | 12 (26) | - | < 0.001 |
| I | 1 (2) | 15 (33) | - | < 0.001 |
| II | 13 (26) | 18 (39) | - | 0.17 |
| III | 27 (54) | 1 (2) | - | < 0.001 |
| IV | 9 (18) | 0 | - | 0.003 |
| ND | 0 | 4 | - | - |
| Anterior domain | ||||
| 0 | 0 | 14 (30) | - | < 0.001 |
| I | 2 (4) | 15 (33) | - | < 0.001 |
| II | 18 (36) | 17 (37) | - | 0.9 |
| III | 26 (52) | 0 | - | < 0.001 |
| IV | 4 (8) | 0 | - | 0.05 |
| ND | 0 | 4 | - | - |
| Apical domain | ||||
| 0 | 5 (10) | 43 (94) | - | < 0.001 |
| I | 5 (10) | 3 (6) | - | 0.5 |
| II | 15 (30) | 0 | - | < 0.001 |
| III | 19 (38) | 0 | - | < 0.001 |
| IV | 6 (12) | 0 | - | 0.002 |
| ND | 0 | 4 | - | - |
| Posterior domain | ||||
| 0 | 1 (2) | 31 (68) | - | < 0.001 |
| I | 25 (53) | 12 (26) | - | 0.008 |
| II | 20 (43) | 2 (4) | - | < 0.001 |
| III | 1 (2) | 1 (2) | - | 0.99 |
| IV | 0 | 0 | - | - |
| ND | 3 | 4 | - | - |
Med median, POP-Q Pelvic Organ Prolapse Quantification, ND non-data
Functional results at follow-up
| PGI-I ( | |
| Better (1–2) | 39 (98) |
| Unchanged (3–4–5) | 1 (2) |
| Worst (6–7) | 0 |
| PFDI-20 ( | Median [IQR] |
| Summary score | 31 [62] |
| POPDI-6 | 4 [21] |
| CRADI-8 | 9 [19] |
| UDI-6 | 8 [25] |
| PFIQ-7 ( | Median [IQR] |
| Summary score | 0 [24] |
| UIQ-7 | 0 [10] |
| CRAIQ-7 | 0 [6] |
| POPIQ-7 | 0 [0] |
| PISQ-IR ( | |
| Sexual activity status | |
| NSA | 23 (46) |
| SA | 14 (28) |
| Scale scores: NSAa | Mean ± SD |
| NSA-PR | 90 ± 27 |
| NSA-CS | 15 ± 36 |
| NSA-GQA | 30 ± 27 |
| NSA-CI | 8 ± 21 |
| Scale scores: SAb | Mean ± SD |
| SA-AO | 55 ± 16 |
| SA-PR | 73 ± 20 |
| SA-CS | 86 ± 16 |
| SA-GQ | 57 ± 30 |
| SA-CI | 93 ± 10 |
| SA-D | 39 ± 14 |
IQR interquartile range, SD standard deviation
Patient Global Impression scale Index
Pelvic Floor Distress Inventory
It included three domains with lower scores associated with better quality of life (min 0—max 300)
POPDI-6 Pelvic Organ Prolapse Distress Inventory (min 0—max 100)
CRADI-8 Colorectal-Anal Distress Inventory (min 0—max 100)
UDI-6 Urinary Distress Inventory (min 0—max 100)
Pelvic Floor Impact Questionnaire
It included three domains with lower scores associated with better quality of life (min 0—max 300)
UIQ-7 Urinary Impact Questionnaire
CRAIQ-7 Colorectal-Anal Impact Questionnaire
POPIQ-7 Pelvic Organ Prolapse Impact Questionnaire
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire
NSA not sexually active
SA sexually active
aHigher scores indicate greater impact of condition on sexual function (high score negative) (min 0–max 100)
bHigher scores indicate better sexual function (high scores positive) (min 0–max 100)
NSA-PR not sexually active: partner related
NSA-CS not sexually active: condition specific
NSA-GQA not sexually active: global quality rating
NSA-CI not sexually active: condition impact
SA-AO sexually active: arousal, orgasm
SA-PR sexually active: partner related
SA-CS sexually active: condition specific
SA-GQ sexually active: global quality
SA-CI sexually active: condition impact
SA-D sexually active: desire